title: [The pharmacological effect of betapressin in hypertension].
abstract: The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance. This circumstance, as well as acceleration of the heart rhythm, leads to increase of the cardiac output. Betapressin is recommended for monotherapy of patients suffering from stages I-II hypertension with eu- and hypokinetic types of hemodynamics.
authors.forename: R M
authors.initials: RM
authors.lastname: Zaslavskaia
authors.forename: K Zh
authors.initials: KZh
authors.lastname: Akhmetov
authors.forename: V A
authors.initials: VA
authors.lastname: Gol'denberg
authors.forename: G V
authors.initials: GV
authors.lastname: Lilitsa
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010394:Penbutolol / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000959:Antihypertensive Agents; D010394:Penbutolol